President Andrea Wilson Attends NCCN's Patient Advocacy Summit
Blue Faery block logo
Donate Now »
Follow on Twitter Follow us on Twitter
Friend on Facebook Follow us on Facebook
Forward to Friend Forward to a Friend

Blue Faery e-Newsletter December 2016 

Share your patient story

Blue Faery is creating a patient advocacy e-book as part of our patient education library of materials. We would love to hear your patient/caregiver stories either in our forum and/or through a short survey. 
Share your story »

Give us advice

Blue Faery has recently joined a special partnership of similar organizations across North America, Asia and Europe in an effort to ask hundreds of men and women with advanced HCC to share their experiences by responding to the first international survey of people living with HCC.
Blue Faery President Andrea Wilson with fellow advocate Melinda Bachini from The Cholangiocarcinoma Foundation

President Andrea Wilson Attends NCCN's Patient Advocacy Summit

On Friday, December 9, President Andrea Wilson attended the National Comprehensive Cancer Network’s (NCCN) Patient Advocacy Summit at the National Press Club in Washington, D.C. The focus was on Value Tools for Patients in Cancer Care. The summit provided an opportunity for a varied group of stakeholders including patients ... Read the story »

Wear our Blue Faery this holiday season

Visit Blue Faery's Boutique to purchase a variety of gifts for your loved ones this holiday season. From clothes to electronics, we have something for everyone. ALL of the proceeds from your purchases help us fight liver cancer.

Apply for the Blue Faery Award by Jan 31

Are you an oncologist? Hepatologist? Transplant surgeon? Do you do Hepatocellular Carcinoma research? Apply for our annual Blue Faery Award Excellence in Liver Cancer Research. Nominations are also accepted.

List your clinical trial

For a nominal fee, you can list your clinical trial on Blue Faery's site, and we will promote it in our newsletter. Bristol-Myers Squibb is recruiting for a Phase III study of nivolumab compared to sorafenib as a primary treatment in HCC patients ... Read more »
Copyright © 2016 Blue Faery: The Adrienne Wilson Liver Cancer Association, All rights reserved.
Email Marketing Powered by Mailchimp
unsubscribe from this list | update subscription preferences